PURPOSE: The purpose of this study was to assess the longitudinal impact of stoma formation on the health-related quality of life of rectal cancer patients treated withadjuvant chemotherapy. METHODS:Health-related quality of life data was prospectively collected in a randomized trial designed to compare 24 weeks of bolus 5-fluorouracil/leucovorin with 12 weeks of continuous 5-fluorouracil in patients with resected Dukes B and C colorectal cancer. Health-related quality of life data was collected at baseline, during adjuvant treatment, and at one and three years after completion of chemotherapy. RESULTS:Between 1993 and 2003, 186 rectal cancer patients were enrolled. One hundred thirty-nine patients had anterior resection, of whom 46 had a temporary defunctioning colostomy. Forty-seven patients had abdominoperineal resection with formation of a permanent colostomy. There was no significant difference in global health-related quality of life between patients with and patients without a stoma at any time point. However, during adjuvant treatment, role (P = 0.04) and social (P = 0.005) functioning were significantly worse in stoma patients than in nonstoma patients. Moreover, the impairment in social functioning persisted at one (P = 0.03) and three years (P = 0.04) after adjuvant chemotherapy. CONCLUSION: Our results demonstrate important adverse effects of either temporary or permanent stoma formation on subsequent health-related quality of life in patients with rectal cancer.
RCT Entities:
PURPOSE: The purpose of this study was to assess the longitudinal impact of stoma formation on the health-related quality of life of rectal cancerpatients treated with adjuvant chemotherapy. METHODS: Health-related quality of life data was prospectively collected in a randomized trial designed to compare 24 weeks of bolus 5-fluorouracil/leucovorin with 12 weeks of continuous 5-fluorouracil in patients with resected Dukes B and C colorectal cancer. Health-related quality of life data was collected at baseline, during adjuvant treatment, and at one and three years after completion of chemotherapy. RESULTS: Between 1993 and 2003, 186 rectal cancerpatients were enrolled. One hundred thirty-nine patients had anterior resection, of whom 46 had a temporary defunctioning colostomy. Forty-seven patients had abdominoperineal resection with formation of a permanent colostomy. There was no significant difference in global health-related quality of life between patients with and patients without a stoma at any time point. However, during adjuvant treatment, role (P = 0.04) and social (P = 0.005) functioning were significantly worse in stoma patients than in nonstoma patients. Moreover, the impairment in social functioning persisted at one (P = 0.03) and three years (P = 0.04) after adjuvant chemotherapy. CONCLUSION: Our results demonstrate important adverse effects of either temporary or permanent stoma formation on subsequent health-related quality of life in patients with rectal cancer.
Authors: Giancarlo D'Ambrosio; Alessandro M Paganini; Andrea Balla; Silvia Quaresima; Pietro Ursi; Paolo Bruzzone; Andrea Picchetto; Fabrizio I Mattei; Emanuele Lezoche Journal: Surg Endosc Date: 2015-06-05 Impact factor: 4.584
Authors: Johannes Klose; Ignazio Tarantino; Armin von Fournier; Moritz J Stowitzki; Yakup Kulu; Thomas Bruckner; Claudia Volz; Thomas Schmidt; Martin Schneider; Markus W Büchler; Alexis Ulrich Journal: J Gastrointest Surg Date: 2018-05-18 Impact factor: 3.452
Authors: E Angenete; A Correa-Marinez; J Heath; E González; A Wedin; M Prytz; D Asplund; E Haglind Journal: Int J Colorectal Dis Date: 2012-03-27 Impact factor: 2.571
Authors: Virginia Sun; Marcia Grant; Carmit K McMullen; Andrea Altschuler; M Jane Mohler; Mark C Hornbrook; Lisa J Herrinton; Carol M Baldwin; Robert S Krouse Journal: J Wound Ostomy Continence Nurs Date: 2013 Jan-Feb Impact factor: 1.741
Authors: Sang Woo Lim; Hun Jin Kim; Chang Hyun Kim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim Journal: Langenbecks Arch Surg Date: 2012-12-09 Impact factor: 3.445
Authors: Lisa J Herrinton; Andrea Altschuler; Carmit K McMullen; Joanna E Bulkley; Mark C Hornbrook; Virginia Sun; Christopher S Wendel; Marcia Grant; Carol M Baldwin; Wendy Demark-Wahnefried; Larissa K F Temple; Robert S Krouse Journal: CA Cancer J Clin Date: 2016-03-21 Impact factor: 508.702